Abstract
The use of polymeric nanoparticles (NPs) in pharmacology provides many benefits because this approach can increase the efficacy and selectivity of active compounds. However, development of new nanocarriers requires better understanding of the interactions between NPs and the immune system, allowing for the optimization of NP properties for effective drug delivery, especially for systemic delivery. Nanopolymers are constructed from biocompatible and biodegradable polymers which are one of the promising trends of biomaterial where the drug is dissolved, entrapped, encapsulated, or attached to a nanoparticle matrix. When biocompatible materials are applied to the body, it is expected to perform a desired response without any side effects. Polymeric NPs represent one of the most innovative noninvasive approaches for drug delivery applications. NPs’ main objective is to convey the therapeutic molecules, including drugs, proteins, and nucleic acids, directly into the target organ or tissue. Many polymers are used for the synthesis of NPs, and among the currently most employed materials, several biocompatible synthetic polymers, namely, polylactic acid (PLA), polylactic-co-glycolic acid (PLGA), and polyethylene glycol (PEG), are well appreciated. These molecules are made of simple monomers which are easily excreted without being toxic. NPs can be modified to target specific cells or cross membrane barriers. In this chapter the various types of biodegradable polymer NPs will be discussed with emphasis on their applications in cancer drug delivery, where both active and passive targeting are used to enhance efficacy and reduce systemic toxicity.
References
Adams GP, Schier R, McCall AM, Simmons HH, Horak EM, Alpaugh RK, Marks JD, Weiner LM (2001) High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules. Cancer Res 61:4750–4755
Adjei IM, Blanka S (2015) Modulation of the tumor microenvironment for cancer treatment: a biomaterials approach. J Funct Biomater 6:81–103
Aji Alex MR, Nehate C, Veeranarayanan S, Kumar DS, Kulshreshtha R, Koul V (2017) Self-assembled dual responsive micelles stabilized with protein for co-delivery of drug and siRNA in cancer therapy. Biomaterials 133:94–106
Azmat AK, Amer MA, Mumtaz J, Arun C, Mohammad AA (2019) Therapeutic potential of functionalized siRNA nanoparticles on regression of liver cancer in experimental mice. Sci Rep 9:15825
Bae YH (2009) Drug targeting and tumor heterogeneity. J Control Release 133:2–3
Beck RCR, Chaves PS, Goyanes A, Vukosavljevic B, Buanz A, Windbergs M, Basit AW, Gaisford S (2017) 3D printed tablets loaded with polymeric nanocapsules: an innovative approach to produce customized drug delivery systems. Int J Pharm 528:268–279
Chen W, Meng F, Cheng R, Zhong Z (2010) pH-Sensitive degradable polymersomes for triggered release of anticancer drugs: a comparative study with micelles. J Control Release 142:40–46
Choi KY, Correa S, Min J, Li J, Roy S, Laccetti KH et al (2019) Binary targeting of siRNA to hematologic cancer cells in vivo using layer-by-layer nanoparticles. Adv Funct Mater 29:1900018
Danhier F, Feron O, Préat V (2010) To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 148:135–146
Ding H, Inoue S, Ljubimov AV et al (2010) Inhibition of brain tumor growth by intravenous poly(b-lmalic) acid nanobioconjugate with pH-dependent drug release. Proc Natl Acad Sci USA 107:18143–18148
Ding H, Portilla-Aries J, Patil R, Black KL, Ljubimova JY, Holler E (2011) Polymalic acid peptide copolymers: design and optimization for endosomolytic drug delivery. Biomaterials 32:5269–5278
Duncan R (2006) Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 6:688–701
El-Andaloussi S, Lee Y, Lakhal-Littleton S, Li J, Seow Y, Gardiner C, Alvarez-Erviti L, Sargent IL, Wood MJA (2012) Exosome-mediated delivery of siRNA in vitro and in vivo. Nat Protoc 7(12):2112–2126
Eleonora C, Alessio C, Alice P, Alessandro DM, Brunella T, Carla E (2019) Biocompatible polymer nanoparticles for drug delivery applications in cancer and neurodegenerative disorder therapies. J Funct Biomater 10:4
Emerich DF, Thanos CG (2006) The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis. Biomol Eng 23:171–184
Fan Y, Moon JJ (2015) Nanoparticle drug delivery systems designed to improve cancer vaccines and immunotherapy. Vaccine 3:662–685
Farokhzad OC, Langer R (2006) Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev 58:1456–1459
Fleige E, Quadir MA, Haag R (2012) Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. Adv Drug Deliv Rev 64:866–884
Gaumet M, Vargas A, Gurny R, Delie F (2008) Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm 69:1–9
Goksu O, Ozgur E, Nurgul KB (2019) Biocompatible nanopolymers in drug delivery systems and their recent electrochemical applications in drug assays. In: Hussain CM, Thomas S (eds) Handbook of polymer and ceramic nanotechnology. © Springer Nature Switzerland AG. https://doi.org/10.1007/978-3-030-10614-0_24-1
Gref R, Lück M, Quellec P, Marchand M, Dellacherie E, Harnisch S, Blunk T, Müller RH (2000) ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces 18:301–313
Grund S, Bauer M, Fischer D (2011) Polymers in drug delivery – state of the art and future trends. Adv Eng Mater 13:B61–B87
Honey PJ, Rijo J, Anju A, Anoop KR (2014) Smart polymers for the controlled delivery of drugs – a concise overview. Acta Pharm Sin B 4:120–127
Inoue S, Ding H, Portilla-Arias J et al (2011) Nanobioconjugate inhibition of HER2/neu signaling and synthesis provides efficient mouse breast cancer treatment. Cancer Res 71:1454–1464
Inoue S, Patil R, Portilla-Arias J et al (2012) Novel nanobioconjugate inhibiting EGFR expression in triple negative breast cancer. PLoS One 7(2):E3107
Khanal S, Adhikari U, Rijal NP, Bhattarai SR, Sankar J, Bhattarai N (2016) pH-responsive PLGA nanoparticle for controlled payload delivery of diclofenac sodium. J Funct Biomater 7:21
Kim HJ, Miyata K, Nomoto T, Zheng M, Kim A, Liu X, Cabral H, James Chridtie R, Nishiyama N, Kataoka K (2014) siRNA delivery from triblock copolymer micelles with spatially-ordered components of PEG shell, siRNA-loaded intermediate layer, and hydrophobic core. Biomaterials 35:4548–4556
Kim H, Niu L, Larson P, Kucaba TA, Murphy KA, James BR, Ferguson DM, Griffith TS, Panyam J (2018) Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy. Biomaterials 164:38–53
Kong N, Deng M, Sun XN, Chen YD, Sui XB (2018) Polydopamine-functionalized CA- (PCL-ran-PLA) nanoparticles for target delivery of docetaxel and chemo-photothermal therapy of breast cancer. Front Pharmacol 9:125
Kopecek J (2010) Kopecková P. HPMA copolymers: origins, early developments, present, and future. Adv Drug Deliv Rev 62:122–149
Koren E, Torchilin VP (2012) Cell-penetrating peptides: breaking through to the other side. Trends Mol Med 18:385–393
Krishna R, Mayer LD (2000) Multidrug resistance (MDR) in cancer: mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci 11:265–283
Kumari A, Yadav SK, Yadav SC (2010) Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 75:1–18
Lammers T (2010) Improving the efficacy of combined modality anticancer therapy using HPMA copolymer-based nanomedicine formulations. Adv Drug Deliv Rev 62:203–230
Lammers T, Subr V, Ulbrich K, Hennink WE, Storm G, Kiessling F (2010) Polymeric nanomedicines for image-guided drug delivery and tumor-targeted combination therapy. Nano Today 5:197–212
Lee JH, Nan A (2012) Combination drug delivery approaches in metastatic breast cancer. J Drug Deliv Vol 2012, p 1–17. https://doi.org/10.1155/2012/915375. Article ID 915375
Li C, Wallace S (2008) Polymer-drug conjugates: recent development in clinical oncology. Adv Drug Deliv Rev 60:886–898
Liu S, Gordiichuk P, Wu Z-S et al (2015) Patterning two-dimensional free-standing surfaces with mesoporous conducting polymers. Nat Commun 6:8817
Liu S, Zhang J, Dong R et al (2016) Two-dimensional mesoscale-ordered conducting polymers. Angew Chem Int Ed 55:12516–12521
Liu Y, Wei M, Hu Y et al (2018) An electrochemical sensor based on a molecularly imprinted polymer for determination of anticancer drug Mitoxantrone. Sensors Actuators B Chem 255:544–551
Ljubimova JY, Holler E (2012) Biocompatible nanopolymers: the next generation of breast cancer treatment? Nanomedicine (Lond) 7(10):1467–1470
Mokhtarzadeh A, Alibakhshi A, Yaghoobi H et al (2016a) Recent advances on biocompatible and biodegradable nanoparticles as gene carriers. Expert Opin Biol Ther 16:771–785
Mokhtarzadeh A, Alibakhshi A, Hejazi M et al (2016b) Bacterial-derived biopolymers advanced natural nanomaterials for drug delivery and tissue engineering. TrAC Trends Anal Chem 82:367–384
Mokhtarzadeh A, Alibakhshi A, Hashemi M et al (2017) Biodegradable nano-polymers as delivery vehicles for therapeutic small non-coding ribonucleic acids. J Control Release 245:116–126
Moraru AD, Costuleanu M, Sava A et al (2014) Intraocular biodistribution of intravitreal injected chitosan/gelatin nanoparticles. Romanian J Morphol Embryol 55:869–875
Nishiyama N, Bae Y, Miyata K, Fukushima S, Kataoka K (2005) Smart polymeric micelles for gene and drug delivery. Drug Discov Today 2:21–26
Park J, Fong PM, Lu J, Russell KS, Booth CJ, Saltzman WM, Fahmy TM (2009) PEGylated PLGA nanoparticles for the improved delivery of doxorubicin. Nanomedicine 5:410–418
Patel MP, Patel RR, Patel JK (2010) Chitosan mediated targeted drug delivery system: a review. J Pharm Pharm Sci 13:536–557
Patil R, Portilla-Arias J, Ding H et al (2010) Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly(b-l-malic acid). Pharm Res 27:2317–2329
Peyton S, Hung VTN, Jeremiah AJ (2019) Tailored silyl ether monomers enable backbone-degradable polynorbornene-based linear, bottlebrush and star copolymers through ROMP. Nat Chem 11:1124–1132
Poo H, Park C, Kwak M-S et al (2010) New biological functions and applications of high-molecular mass poly-g-glutamic acid. Chem Biodivers 7:1555–1562
Rani S, Gothwal A, Khan I et al (2018) Smartly engineered PEGylated di-block Nanopolymeric micelles: duo delivery of isoniazid and rifampicin against Mycobacterium tuberculosis. AAPS PharmSciTech 19:3237–3248
Roy A, Singh MS, Upadhyay P, Bhaskar S (2010) Combined chemo-immunotherapy as a prospective strategy to combat cancer: a nanoparticle based approach. Mol Pharm 7:1778–1788
Rozema DB, Lewis DL, Wakefield DH, Wong SC, Klein JJ, Roesch PL, Bertin SL, Reppen TW, Chu Q, Blokhin AV, Hagstrom JE, Wolff JA (2007) Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc Natl Acad Sci USA 104:12982–12987
Rudzinski WE, Aminabhavi TM (2010) Chitosan as a carrier for targeted delivery of small interfering RNA. Int J Pharm 399:1–11
Sanna V, Singh CK, Jashari R, Adhami VM, Chamcheu JC, Rady I, Sechi M, Mukhtar H, Siddiqui IA (2017) Targeted nanoparticles encapsulating (-)-epigallocatechin-3- gallate for prostate cancer prevention and therapy. Sci Rep 7:41573
Sawant RM, Hurley JP, Salmaso S, Kale A, Tolcheva E, Levchenko TS, Torchilin VP (2006) “SMART” drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjug Chem 17:943–949
Shafiei-Irannejad V, Samadi N, Salehi R, Yousefi B, Rahimi M, Akbarzadeh A, Zarghami N (2018) Reversion of multidrug resistance by co-encapsulation of doxorubicin and metformin in poly (lactide-co-glycolide)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles. Pharm Res 35:119
Shi Z, Gao X, Ullah MW et al (2016) Electroconductive natural polymer-based hydrogels. Biomaterials 111:40–54
So JL, Min JK, Ick CK, Thomas MR (2016) Delivery strategies and potential targets for siRNA in major cancer types. Adv Drug Deliv Rev 104:2–15
Subhan MA, Torchilin VP (2020) siRNA based drug design, quality, delivery and clinical translation. Nanomedicine 29:102239
Sylwia Ł, Krzysztof S, Ewa B, Marta DW (2015) Biocompatible polymeric nanoparticles as promising candidates for drug delivery. Langmuir 31:6415–6425
Torchilin VP (2001) Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 73:137–172
Torchilin VP (2011) Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 63:131–135
Varshosaz J (2012) Dextran conjugates in drug delivery. Expert Opin Drug Deliv 9:509–523
Wahlgren J, Karlson TDL, Brisslert M, Sani FV, Telemo E, Sunnerhagen P, Valadi H (2012) Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res 40:130
Wang JJ, Zeng ZW, Xiao RZ et al (2011) Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomedicine 6:765–774
Wissing SA, Kayser O, Müller RH (2004) Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 56:1257–1272
Xin H, Jiang X, Gu J et al (2011) Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Biomaterials 32:4293–4305
Yadavalli T, Ramasamy S, Chandrasekaran G et al (2015) Dual responsive PNIPAM–chitosan targeted magnetic nanopolymers for targeted drug delivery. J Magn Magn Mater 380:315–320
Yea H, Jina L, Hua R et al (2006) Poly(g,l-glutamic acid)–cisplatin conjugate effectively inhibits human breast tumor xenografted in nude mice. Biomaterials 27:5958–5965
Yi L, Thavasyappan T, Doo SL (2018) Co-delivery of drugs and genes using polymeric nanoparticles for synergistic cancer therapeutic effects. Adv Healthc Mater 7:1700886
Yong KS, Sung WK (2020) Recent advances in polymeric drug delivery systems. Biomaterials Research 24(1):12
Further Reading
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this entry
Cite this entry
Subhan, M.A., Torchilin, V.P. (2021). Biocompatible Polymeric Nanoparticles as Promising Candidates for Drug Delivery in Cancer Treatment. In: Hussain, C.M., Thomas, S. (eds) Handbook of Polymer and Ceramic Nanotechnology. Springer, Cham. https://doi.org/10.1007/978-3-030-10614-0_80-1
Download citation
DOI: https://doi.org/10.1007/978-3-030-10614-0_80-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-10614-0
Online ISBN: 978-3-030-10614-0
eBook Packages: Springer Reference Chemistry and Mat. ScienceReference Module Physical and Materials ScienceReference Module Chemistry, Materials and Physics